11
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Comparison of chemotaxis and superoxide generation of indium-111-oxine- and technetium-99m-HMPAO-labelled granulocytes

, , &
Pages 305-309 | Received 24 Nov 1995, Accepted 07 Feb 1996, Published online: 08 Jul 2009

References

  • McAfee J G, Thakur M L. Survey of radioactive agents for in vitro labelling of phagocytic leucocytes. 1. Soluble agents. J Nucl Med 1976; 17: 480–7
  • Peters A M, Danpure H J, Osman S, Hawker R J, Henderson B L, Hodgson H J, et al. Clinical experience with Tc-99m-Hexamethylpropyleneamineoxime for labelling leucocytes and imaging inflammation. Lancet 1986; 2: 946–9
  • Costa D C, Lui D, Ell P J. White cells radiolabelled with In-111 and Tc-99m—a study of relative sensitivity and in vivo viability. Nucl Med Comm 1988; 9: 725–31
  • Becker W, Schonmann E, Fischbach W, Boerner W, Gruner K R. Comparison of Tc-99m-HMPAO-and In-111-oxine-labeled granulocytes in man; first clinical results. Nucl Med Comm 1988; 9: 435–47
  • Aktolun C, Ussov W Y, Arka A, Glass D, Gunasekera R D, Peters A M. Technitium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies. Eur J Nucl Med 1995; 22: 330–4
  • Arndt J W, van der Sluys Veer A, Blok D, Griffioen G, Verspaget H W, Lamers C BHW, et al. Prospective comparative study of technitium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med 1993; 34: 1052–7
  • Zakireh B, Thakur M L, Malech H L, Cohen M S, Gottschalk A, Root R K. Indium-111-labeled human polymorphonuclear leucocytes: viability, random migration, chemotaxis, bactericidal capacity and ultrastructure. J Nucl Med 1979; 20: 741–7
  • Mortelmans L, Malbrain S, Stuyck J, de Backker C, Heynen M J, Boogaerts M, et al. In vitro and in vivo evaluation of granulocyte labeling with [99mTc]d, 1-HM-PAO. J Nucl Med 1989; 30: 2022–28
  • Zimmerli W, Seligmann B, Gallin J I. Exudation primes human and gumea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest 1986; 77: 925–33
  • Zimmerli W, Reber A, Dahinden C A. The role of formylpeptide receptors, C5a-receptors and cytosolic-free calcium in neutrophil priming. J Infect Dis 1990; 61: 242–9
  • Davies J M, Dineen P, Gallin J. Neutrophil degranulation and abnormal chemotaxis after thermal injury. J Immunol 1980; 124: 1467–71
  • Donabedian H, Gallin J I. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-LeuPhe. J Immunol 1981; 127: 839–44
  • Falk W, Goodwin R H, Jr, Leonard E J. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. Immunol Meth 1980; 33: 239–7
  • Jacob H S, Craddock P R, Hammerschmidt D E, Moldow C F. Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 1980; 302: 789–94
  • Saverymuttu S H, Peters A M, Danpure H J, Reavy H J, Osman S, Lavender J P. Lung transit of 111In labelied granulocytes. Relationship to labelling techniques. Scand J Haematol 1983; 30: 151–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.